Immunogenic SARS-CoV2 Epitopes Defined by Mass Spectrometry.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
21 Jul 2021
Historique:
entrez: 27 7 2021
pubmed: 28 7 2021
medline: 28 7 2021
Statut: epublish

Résumé

SARS-CoV-2 infections elicit both humoral and cellular immune responses. For the prevention and treatment of COVID19, the disease caused by SARS-CoV-2, T cell responses are important in mediating recovery and immune-protection. The identification of immunogenic epitopes that can elicit a meaningful T cell response can be elusive. Traditionally, this has been achieved using sophisticated Current state of the art uses putative epitope peptides based on

Identifiants

pubmed: 34312620
doi: 10.1101/2021.07.20.453160
pmc: PMC8312890
pii:
doi:

Types de publication

Preprint

Langues

eng

Auteurs

Classifications MeSH